Stanford #Melanoma’s @funchainmd.bsky.social leading us through a fantastic discussion of immune checkpoint toxicity #irAE in patients with pre-existing autoimmune disease. #CMC26 @stanforduniversity.bsky.social
fanart of alcy's OC Ellioth, a blonde man with a rainbow feather in his long hair. he's rather thin, and holding a book with architecture notes :)
Ellioth ! @alcyoneum.bsky.social #irae
doodles of Darae, the fem version of the OG Darass. she stands in a fairly serious way, saying "what brings you here, Penserive ?", there's also a less visible sketch of her saying "Émil... what a nice name..."
Darae!!! #irae
New study: blood test using #cfDNA methylation detects multiorgan damage from immune checkpoint inhibitors — found in all patients with #irAE, sometimes weeks before symptoms. Suggests therapy causes systemic loss of immune tolerance. www.nejm.org/doi/full/10.... @funchainmd.bsky.social
🔍 Learn more about EMAS official journals and their contribution to advancing clinical education.
https://www.emas-online.org/journals/
#CRWH #WomensHealth #EndometrialCancer #Oncology #Immunotherapy #irAE #EMAS
halfbody sketch of Cercle with rough colors and textures. she looks at the viewer with an intense look while doing her puppeteering in the background
cabildoabierto.ar/perfil/semantic-web.bsky.social
#PIZZA #BOX #DISSENY
multi-search-tag-explorer.headlines-world.com/advanced-sea...
#DIES #IRAE
multi-search-tag-explorer.headlines-world.com/advanced-sea...
blueskystarterpack.com/starter-pack...
How does #toxicity from #immunotherapy affect the real world patient?
Northern Norway we investigated #irAES in different #ICI combinations, with 40% of the patients experienced an #CTCAE grade 2 or more #irAE, leading to hospitalization or becoming chronic.
www.tandfonline.com/doi/full/10....
image_0
IRAE (Portugal) presenta nou àlbum: "In the Key of Twilight" #Irae #BlackMetal #Novembre2025 #Portugal #NouÀlbum #Metall #Metal #MúsicaMetal #MetalMusic
FULL FORCE FRIDAY:🆕November 28th3⃣5⃣🎧
IRAE (PT) - In the Key of Twilight 🇵🇹💠
7th album from Lisbon, Portuguese Black Metal project💠
BC➡️irae666.bandcamp.com/album/in-the...💠
#Irae #InTheKey #BlackMetal #signal_rex #FFFNov28 #KMäN
#METALSKY
#BLACKMETAL
#IRAE
#NEWALBUM
spak-individualthoughtpatterns.blogspot.com/2025/11/irae...
Sign up now! 2026 ASPIRE-IOTOX Symposium at MDAnderson April 24-25, 2026. Join us to discuss #irAE! mdanderson.cloud-cme.com/course/cours... @funchainmd.bsky.social @kerryreynoldsmd.bsky.social @kmittalmd.bsky.social
#METALSKY
#BLACKMETAL
#IRAE
#RELEASEDATE
spak-individualthoughtpatterns.blogspot.com/2025/11/irae...
#METALSKY
#BLACKMETAL
#IRAE
#NEWMUSIC
spak-individualthoughtpatterns.blogspot.com/2025/10/irae...
New review article on our journal: Reprogramming the tumor microenvironment: synergistic mechanisms of antibody–drug conjugates and immune checkpoint inhibitors
doi.org/10.1093/abt/...
#OpenAccess #ADC #ICI #TME #irAE #IMER #Oncology
Mark your calendars! ASPIRE-IOTOX Symposium April 24-25, 2026 at MD Anderson Cancer Center #irAE #immunotherapy @sitcancer.bsky.social @ascocancer.bsky.social @funchainmd.bsky.social @kerryreynoldsmd.bsky.social @kmittalmd.bsky.social @mdanderson.bsky.social
📘 Just launched: the first-ever clinical casebook focused solely on immune-related toxicities. 65 expert-contributed cases across 10+ organ systems. Essential reading for the #irAE frontlines. Grab your copy 👉 link.springer.com/book/10.1007...
#irAE #OncologyBooks @ascocancer.bsky.social #ASPIRE
🧠 Stay sharp with the latest in #irAE research! From duplilumab in cutaneous toxicities to survival outcomes with inpatient ICI use—our curated #ASPIRE reading list 🔥.
Start reading now in our latest newsletter: mailchi.mp/325da8534919...
#Immunotherapy #irAE #MedEd @kmittalmd.bsky.social
Missed #ASPIRE June 17 webinar? 🎥 Now available on-demand! Dive into cutting-edge #ASCO updates on #irAE education, biomarkers, & translation. Must watch the evolving #immunotherapy landscape. 🎯 Link in our latest newsletter:
mailchi.mp/325da8534919... @funchainmd.bsky.social
Caroline Robert asks if we should move away from CTCAE grading of irAE in trials and acknowledge the AI (which she notes is more likely focal hypopit rather than AI) is actually a 6% rate of permanent medication-requiring disease #irAE #ASCO25 #melsm @ascocancer.bsky.social @aspire-cop.bsky.social
Discussion of 1st set of melanoma orals by Ana Arance - Toxicities are the *key* challenge in the adjuvant setting and mitigation of #irAE are the priority in this setting #ASCO25
@ascocancer.bsky.social @aspire-cop.bsky.social
Neoadj ipi/nivo is clear winner in melanoma, prompting Genevieve Boland and Diwakar Davar to discuss the CONSTANT communication required between med onc/ surg onc (and relevant subspecialists) perioperatively to address ir-AI or colitis #ASCO25 #irAE @ascocancer.bsky.social @aspire-cop.bsky.social